Autophagy and Non-Alcoholic Fatty Liver Disease

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lavallard, Vanessa J ^a,b   Gual, Philippe ^a,b,c  

^a CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY RELATED PROTEIN 7; BECLIN 1; CALPAIN 2; CATHEPSIN L; FAT DROPLET; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PEPTIDES AND PROTEINS; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EB; TRANSCRIPTION FACTOR FOXO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGING; APOPTOSIS; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CARDIOVASCULAR RISK; CELL ACTIVATION; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; FATTY ACID ANALYSIS; FATTY LIVER; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID COMPOSITION; LIPID STORAGE; LIPOPHAGOCYTOSIS; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LYSOSOME; MACROAUTOPHAGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OVERNUTRITION; REVIEW; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; PROTEIN DEGRADATION; PROTEIN UNFOLDING;

AUTOPHAGY; CARCINOMA, HEPATOCELLULAR; FATTY LIVER; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PROTEIN UNFOLDING; PROTEOLYSIS;

EID: 84921475513     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/120179     Document Type: Review

References (95)

1. T. Yorimitsu and D. J. Klionsky, "Autophagy: A molecularmachinery for self-eating, " Cell Death and Differentiation, vol. 12, supplement 2, pp. 1542-1552, 2005.
2. P. Codogno and A. J. Meijer, "Autophagy and signaling: A their role in cell survival and cell death, " Cell Death and Differentiation, vol. 12, no. 2, pp. 1509-1518, 2005.
3. A. Ciechanover, A. Orian, and A. L. Schwartz, "Ubiquitin-mediated proteolysis: A biological regulation via destruction, " Bioessays, vol. 22, pp. 442-451, 2000.
4. N. B. Nedelsky, P. K. Todd, and J. P. Taylor, "Autophagy and the ubiquitin-proteasome system: A collaborators in neuroprotection, " Biochimica et Biophysica Acta: A Molecular Basis of Disease, vol. 1782, no. 12, pp. 691-699, 2008.
5. E. L. Axe, S. A. Walker, M. Manifava et al., "Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum, " Journal of Cell Biology, vol. 182, no. 4, pp. 685-701, 2008.
6. M.Hayashi-Nishino, N. Fujita, T.Noda, A.Yamaguchi, T.Yoshimori, and A. Yamamoto, "A subdomain of the endoplasmic reticulumforms a cradle for autophagosome formation, " Nature Cell Biology, vol. 11, no. 12, pp. 1433-1437, 2009.
7. P. Ylä-Anttila, H. Vihinen, E. Jokitalo, and E.-L. Eskelinen, "3D tomography reveals connections between the phagophore and endoplasmic reticulum, " Autophagy, vol. 5, no. 8, pp. 1180-1185, 2009.
8. M. Mari, S. A. Tooze, and F. Reggiori, "The puzzling origin of the autophagosomal membrane, " F1000 Biology Reports, vol. 3, p. 25, 2011.
9. E. Arias and A. M. Cuervo, "Chaperone-mediated autophagy in protein quality control, " Current Opinion in Cell Biology, vol. 23, no. 2, pp. 184-189, 2011.
10. H. Nakatogawa, K. Suzuki, Y. Kamada, and Y. Ohsumi, "Dynamics and diversity in autophagy mechanisms: A lessons from yeast, " Nature Reviews Molecular Cell Biology, vol. 10, no. 7, pp. 458-467, 2009.
11. E. Y. W. Chan, A. Longatti, N. C. McKnight, and S. A. Tooze, "Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism, " Molecular and Cellular Biology, vol. 29, no. 1, pp. 157-171, 2009.
12. E. Y. Chan, "MTORC1 phosphorylates the ULK1-mAtg13- FIP200 autophagy regulatory complex, " Science Signaling, vol. 2, no. 84, article pe51, 2009.
13. N.Mizushima and M. Komatsu, "Autophagy: A renovation of cells and tissues, " Cell, vol. 147, no. 4, pp. 728-741, 2011.
14. Y. Ohsumi, "Molecular dissection of autophagy: A two ubiquitinlike systems, " Nature Reviews Molecular Cell Biology, vol. 2, no. 3, pp. 211-216, 2001.
15. Y. Kabeya, N.Mizushima, A. Yamamoto, S. Oshitani-Okamoto, Y. Ohsumi, and T. Yoshimori, "LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation, " Journal of Cell Science, vol. 117, no. 13, pp. 2805-2812, 2004.
16. D. J. Klionsky, F. C. Abdalla, H. Abeliovich et al., "Guidelines for the use and interpretation of assays for monitoring autophagy, " Autophagy, vol. 8, no. 4, pp. 445-544, 2012.
17. H. M. Shen and N. Mizushima, "At the end of the autophagic road: A n emerging understand ing of lysosomal functions in autophagy, " Trends in Biochemical Sciences, vol. 39, pp. 61-71, 2014.
18. H. Koga, S. Kaushik, and A.M. Cuervo, "Altered lipid content inhibits autophagic vesicular fusion, " The FASEB Journal, vol. 24, no. 8, pp. 3052-3065, 2010.
19. C. Settembre, C. Di Malta, V. A. Polito et al., "TFEB links autophagy to lysosomal biogenesis, " Science, vol. 332, no. 6036, pp. 1429-1433, 2011.
20. C. Settembre, R. De Cegli, G. Mansueto et al., "TFEB controls cellular lipidmetabolism through a starvation-induced autoregulatory loop, " Nature Cell Biology, vol. 15, no. 8, pp. 647-658, 2013.
21. O. T.Hardy, M. P. Czech, and S. Corvera, "What causes the insulin resistance underlying obesity? Current Opinion in Endocrinology, Diabetes and Obesity, vol. 19, no. 2, pp. 81-87, 2012.
22. A. Tran and P. Gual, "Non-alcoholic steatohepatitis inmorbidly obese patients, " Clinics and Research in Hepatology and Gastroenterology, vol. 37, no. 1, pp. 17-29, 2013.
23. V. J.Lavallard, A. J.Meijer, P. Codogno, and P.Gual, "Autophagy, signaling and obesity, " Pharmacological Research, vol. 66, no. 6, pp. 513-525, 2012.
24. L.Yang, P. Li, S.Fu, E. S. Calay, and G.S.Hotamisligil, "Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance, " Cell Metabolism, vol. 11, no. 6, pp. 467-478, 2010.
25. P. Gual, Y. le Marchand -Brustel, and J. F. Tanti, "Positive and negative regulation of insulin signaling through IRS-1 phosphorylation, " Biochimie, vol. 87, no. 1, pp. 99-109, 2005.
26. F. Tremblay, M. Krebs, L. Dombrowski et al., "Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability, " Diabetes, vol. 54, no. 9, pp. 2674-2684, 2005.
27. H. Y. Liu, J. Han, S. Y. Cao et al., "Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia. Inhibition of FoxO1-dependent expression of key autophagy genes by insulin, " Journal of Biological Chemistry, vol. 284, no. 45, pp. 31484-31492, 2009.
28. Y. Inami, S. Yamashina, K. Izumi et al., "Hepatic steatosis inhibits autophagic proteolysis via impairment of autophagosomal acidification and cathepsin expression, " Biochemical and Biophysical Research Communications, vol. 412, no. 4, pp. 618-625, 2011.
29. Y. Fukuo, S. Yamashina, H. Sonoue et al., "Abnormality of autophagic function and cathepsin expression in the liver from patients with non-alcoholic fatty liver disease, " Hepatology Research, 2014.
30. G. S. Hotamisligil, "Endoplasmic reticulum stress and the inflammatory basis of metabolic disease, " Cell, vol. 140, no. 6, pp. 900-917, 2010.
31. R. Singh, S. Kaushik, Y. Wang et al., "Autophagy regulates lipid metabolism, " Nature, vol. 458, no. 7242, pp. 1131-1135, 2009.
32. M. Shibata, K. Yoshimura, N. Furuya et al., "The MAP1-LC3 conjugation system is involved in lipid droplet formation, " Biochemical and Biophysical Research Communications, vol. 382, no. 2, pp. 419-423, 2009.
33. K. Liu, J. Lou, T. Wen et al., "Depending on the stage of hepatosteatosis, p53 causes apoptosis primarily through either DRAM-induced autophagy or BAX, " Liver International, vol. 33, pp. 1566-1574, 2013.
34. K. H. Kim, Y. T. Jeong, H. Oh et al., "Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine, " Nature Medicine, vol. 19, no. 1, pp. 83-92, 2013.
35. J. Shen, H. L.-Y. Chan, G. L.-H.Wong et al., "Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers, " Journal of Hepatology, vol. 56, no. 6, pp. 1363-1370, 2012.
36. A. C. Adams, C. A.Halstead, B. C.Hansen et al., "LY2405319, an engineered FGF21 variant, improves the metabolic status of diabeticmonkeys, " PLoSONE, vol. 8, no. 6, Article IDe65763, 2013.
37. A. Kharitonenkov, J. M. Beals, R. Micanovic et al., "Rational design of a fibroblast growth factor 21-based clinical cand idate, LY2405319, " PLoS ONE, vol. 8, no. 3, Article ID e58575, 2013.
38. G. Gaich, J. Y. Chien, and H. Fu, "The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes, " Cell Metabolism, vol. 18, pp. 333-340, 2013.
39. M. Komatsu, S. Waguri, T. Ueno et al., "Impairment of starvation- induced and constitutive autophagy in Atg7-deficient mice, " Journal of Cell Biology, vol. 169, no. 3, pp. 425-434, 2005.
40. G.Mariño, F. Pietrocola, T. Eisenberg et al., "Regulation of autophagy by cytosolic acetyl-coenzyme A, " Molecular Cell, vol. 53, no. 5, pp. 710-725, 2014.
41. C.-W. Lin, H. Zhang, M. Li et al., "Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice, " Journal of Hepatology, vol. 58, no. 5, pp. 993-999, 2013.
42. C. E. Ruhl and J. E. Everhart, "Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States, " Gastroenterology, vol. 128, no. 1, pp. 24-32, 2005.
43. J. W. Molloy, C. J. Calcagno, C. D. Williams, F. J. Jones, D. M. Torres, and S. A. Harrison, "Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis, " Hepatology, vol. 55, no. 2, pp. 429-436, 2012.
44. R. Anty, S. Marjoux, A. Iannelli et al., "Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery, " Journal of Hepatology, vol. 57, no. 5, pp. 1090-1096, 2012.
45. R. A. Sinha, B. L. Farah, B. K. Singh et al., "Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice, " Hepatology, vol. 59, pp. 1366-1380, 2014.
46. W. X.Ding, "Drinking coffee burns hepatic fat by inducing lipophagy coupled with mitochondrial beta-oxidation, " Hepatology, vol. 59, pp. 1235-1238, 2014.
47. P. Codogno and A. J. Meijer, "Autophagy: A potential link between obesity and insulin resistance, " Cell Metabolism, vol. 11, no. 6, pp. 449-451, 2010.
48. H. P. Harding, H. Zeng, Y. Zhang et al., "Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival, " Molecular Cell, vol. 7, no. 6, pp. 1153-1163, 2001.
49. H. Kaneto, T.-A.Matsuoka, Y. Nakatani et al., "Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes, " Journal of Molecular Medicine, vol. 83, no. 6, pp. 429-439, 2005.
50. H. L. Kammoun, H. Chabanon, I. Hainault et al., "GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice, " Journal of Clinical Investigation, vol. 119, no. 5, pp. 1201-1215, 2009.
51. U. Özcan, Q. Cao, E. Yilmaz et al., "Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes, " Science, vol. 306, no. 5695, pp. 457-461, 2004.
52. M.Amir and M. J. Czaja, "Autophagy innonalcoholic steatohepatitis, " Expert Review of Gastroenterology and Hepatology, vol. 5, no. 2, pp. 159-166, 2011.
53. E. M. Brunt, C. G. Janney, A. M. Di Bisceglie, B. A. Neuschwander-Tetri, and B. R. Bacon, "Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions, " The American Journal of Gastroenterology, vol. 94, no. 9, pp. 2467-2474, 1999.
54. D. E. Kleiner, E. M. Brunt, M. Van Natta et al., "Design and validation of a histological scoring systemfor nonalcoholic fatty liver disease, " Hepatology, vol. 41, no. 6, pp. 1313-1321, 2005.
55. P. Bedossa, C. Poitou, N. Veyrie et al., "Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients, " Hepatology, vol. 56, no. 5, pp. 1751-1759, 2012.
56. M. Harada, S. Hanada, D. M. Toivola, N. Ghori, and M. B. Omary, "Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitormediated formation, " Hepatology, vol. 47, no. 6, pp. 2026-2035, 2008.
57. A. Gonzalez-Rodriguez, R. Mayoral, N. Agra et al., "Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD, " Cell Death & Disease, vol. 5, Article IDe1179, 2014.
58. A. Sica, P. Invernizzi, and A.Mantovani, "Macrophage plasticity and polarization in liver homeostasis and pathology, " Hepatology, vol. 59, no. 5, pp. 2034-2042, 2014.
59. A. Sica and A.Mantovani, "Macrophage plasticity and polarization: A in vivo veritas, " The Journal of Clinical Investigation, vol. 122, no. 3, pp. 787-795, 2012.
60. C. C. Mihalache and H. U. Simon, "Autophagy regulation in macrophages and neutrophils, " Experimental Cell Research, vol. 318, no. 11, pp. 1187-1192, 2012.
61. D. J. Puleston and A. K. Simon, "Autophagy in the immune system, " Immunology, vol. 141, no. 1, pp. 1-8, 2014.
62. P. Chen, M. Cescon, and P. Bonaldo, "Autophagy-mediated regulation of macrophages and its applications for cancer, " Autophagy, vol. 10, no. 2, pp. 192-200, 2014.
63. C. S. Shi, K. Shenderov, N. N. Huang et al., "Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction, " Nature Immunology, vol. 13, no. 3, pp. 255-263, 2012.
64. E. Novo, S. Cannito, C. Paternostro, C. Bocca, A.Miglietta, and M. Parola, "Cellular and molecular mechanisms in liver fibrogenesis, " Archives of Biochemistry and Biophysics, vol. 548, pp. 20-37, 2014.
65. R. P. Witek, W. C. Stone, F. G. Karaca et al., "Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis, " Hepatology, vol. 50, no. 5, pp. 1421-1430, 2009.
66. D. L. Diab, L. Yerian, P. Schauer et al., "Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients, " Clinical Gastroenterology and Hepatology, vol. 6, no. 11, pp. 1249-1254, 2008.
67. V. J. Lavallard, S. Bonnafous, S. Patouraux et al., "Serummarkers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease, " PLoS ONE, vol. 6, no. 3, Article ID e17599, 2011.
68. V. Hernndezgea, Z. Ghiassinejad, R. Rozenfeld et al., "Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues, " Gastroenterology, vol. 142, no. 4, pp. 938-946, 2012.
69. L.F.Thoen, E. L.Guimaraes, L.Dolle et al., "Arole for autophagy during hepatic stellate cell activation, " Journal of Hepatology, vol. 55, no. 6, pp. 1353-1360, 2011.
70. V. Hernánd ez-Gea, M. Hilscher, R. Rozenfeld et al., "Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy, " Journal of Hepatology, vol. 59, no. 1, pp. 98-104, 2013.
71. H. Malhi and G. J. Gores, "Cellular and molecular mechanisms of liver injury, " Gastroenterology, vol. 134, no. 6, pp. 1641-1654, 2008.
72. C. Mitchell, M.-A. Robin, A. Mayeuf et al., "Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice, " American Journal of Pathology, vol. 175, no. 5, pp. 1929-1937, 2009.
73. J.-F. Dufour, C. M. Oneta, J.-J. Gonvers et al., "Rand omized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis, " Clinical Gastroenterology and Hepatology, vol. 4, no. 12, pp. 1537-1543, 2006.
74. M. Haedrich and J.-F. Dufour, "UDCA for NASH: A end of the story? Journal of Hepatology, vol. 54, no. 5, pp. 856-858, 2011.
75. Z. Wang, W. Han, X. Sui, Y. Fang, and H. Pan, "Autophagy: A novel therapeutic target for hepatocarcinoma (review), " Oncology Letters, vol. 7, pp. 1345-1351, 2014.
76. X. Qu, J. Yu, G. Bhagat et al., "Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene, " Journal of Clinical Investigation, vol. 112, no. 12, pp. 1809-1820, 2003.
77. A. Takamura, M. Komatsu, T. Hara et al., "Autophagy-deficient mice develop multiple liver tumors, " Genes and Development, vol. 25, no. 8, pp. 795-800, 2011.
78. Z.-B. Ding, Y.-H. Shi, J. Zhou et al., "Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma, " Cancer Research, vol. 68, no. 22, pp. 9167-9175, 2008.
79. J. D. Yang, S.-Y. Seol, S.-H. Leem et al., "Genes associated with recurrence of hepatocellular carcinoma: A integrated analysis by gene expression and methylation profiling, " Journal of Korean Medical Science, vol. 26, no. 11, pp. 1428-1438, 2011.
80. J.-H. Kim, H. Y. Kim, Y.-K. Lee et al., "Involvement of mitophagy in oncogenic K-Ras-induced transformation: A overcoming a cellular energy deficit fromglucose deficiency, " Autophagy, vol. 7, no. 10, pp. 1187-1198, 2011.
81. P. Chen and P. Bonaldo, "Role of macrophage polarization in tumor angiogenesis and vessel normalization: A implications for new anticancer therapies, " International Review of Cell and Molecular Biology, vol. 301, pp. 1-35, 2013.
82. B.-Z. Qian and J. W. Pollard, "Macrophage diversity enhances tumor progression and metastasis, " Cell, vol. 141, no. 1, pp. 39-51, 2010.
83. H. Lin, J. Yan, Z.Wang et al., "Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice, " Hepatology, vol. 57, no. 1, pp. 171-182, 2013.
84. W. Chen, T.Ma, X.-N. Shen et al., "Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway, " Cancer Research, vol. 72, no. 6, pp. 1363-1372, 2012.
85. C. Toso, S. Merani, D. L. Bigam, A. M. J. Shapiro, and N. M. Kneteman, "Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma, " Hepatology, vol. 51, no. 4, pp. 1237-1243, 2010.
86. A. M. Cuervo, E. Bergamini, U. T. Brunk, W.Dröge, M. Ffrench, and A. Terman, "Autophagy and aging: A the importance of maintaining clean cells, " Autophagy, vol. 1, no. 3, pp. 131-140, 2005.
87. W.-L. Yen and D. J. Klionsky, "How to live long and prosper: A autophagy, mitochondria, and aging, " Physiology, vol. 23, no. 5, pp. 248-262, 2008.
88. M. K. Shigenaga, T. M. Hagen, and B. N. Ames, "Oxidative damage and mitochondrial decay in aging, " Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 23, pp. 10771-10778, 1994.
89. E. Bergamini, G. Cavallini, A. Donati, and Z. Gori, "The role of autophagy in aging: A its essential part in the anti-agingmechanism of caloric restriction, " Annals of the New York Academy of Sciences, vol. 1114, pp. 69-78, 2007.
90. S.Miwa, C. Lawless, and T. von Zglinicki, "Mitochondrial turnover in liver is fast in vivo and is accelerated by dietary restriction: A application of a simple dynamic model, " Aging Cell, vol. 7, no. 6, pp. 920-923, 2008.
91. A. J.Meijer and P. Codogno, "Autophagy: A regulation and role in disease, " Critical Reviews in Clinical Laboratory Sciences, vol. 46, no. 4, pp. 210-240, 2009.
92. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, "Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes, " Endocrine Reviews, vol. 23, no. 5, pp. 599-622, 2002.
93. B. B. Lowell and G. I. Shulman, "Mitochondrial dysfunction and type 2 diabetes, " Science, vol. 307, no. 5708, pp. 384-387, 2005.
94. L. Guarente, "Mitochondria-a nexus for aging, calorie restriction, and sirtuins? Cell, vol. 132, no. 2, pp. 171-176, 2008.
95. L. Fontana, E. Zhao, M. Amir, H. Dong, K. Tanaka, and M. J. Czaja, "Aging promotes the development of diet-induced murine steatohepatitis but not steatosis, " Hepatology, vol. 57, no. 3, pp. 995-1004, 2013.